Phase I Study to Determine the Safety of E7070 in Patients With a Solid Tumor as a Single IV Infusion Weekly X 4, Repeated Every 6 Weeks.
Phase of Trial: Phase I
Latest Information Update: 21 Nov 2015
At a glance
- Drugs Indisulam (Primary)
- Indications Solid tumours
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- 10 Jul 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 24 Sep 2005 New trial record.